Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Husain

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Translational Psychiatry|May 20, 2020
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disordersAndré F Carvalho, Marco Solmi, Marcos Sanches, et al.
Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders|October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 8, 2025
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysisMikkel Højlund, Helin Y Kafali, Begüm Kırmızı, et al.
The New England Journal of Medicine|November 2, 2022
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major DepressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Translational Psychiatry|May 20, 2020
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disordersAndré F Carvalho, Marco Solmi, Marcos Sanches, et al.
Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders|October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 8, 2025
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysisMikkel Højlund, Helin Y Kafali, Begüm Kırmızı, et al.
The New England Journal of Medicine|November 2, 2022
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major DepressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Pageof 14